Prescription Drugs: State Monitoring Programs Provide Useful Tool to Reduce Diversion

PDF Version Also Available for Download.

Description

A letter report issued by the General Accounting Office with an abstract that begins "Prescription drug diversion is the channeling of pharmaceuticals for illegal purposes or abuse. According to the Drug Enforcement Administration (DEA), increased prescription drug abuse and emergency room admissions, as well as the theft and illegal resale of prescription drugs, indicate that drug diversion is a growing problem associated with addiction, overdose, and death. All 15 state prescription drug monitoring programs (PDMP) collect information about the prescribing, dispensing, and use of prescription drugs and distribute it to medical practitioners, pharmacies, and state law enforcement and regulatory agencies. ... continued below

Creation Information

United States. General Accounting Office. May 17, 2002.

Context

This report is part of the collection entitled: Government Accountability Office Reports and was provided by UNT Libraries Government Documents Department to Digital Library, a digital repository hosted by the UNT Libraries. It has been viewed 14 times . More information about this report can be viewed below.

Who

People and organizations associated with either the creation of this report or its content.

Publisher

Provided By

UNT Libraries Government Documents Department

Serving as both a federal and a state depository library, the UNT Libraries Government Documents Department maintains millions of items in a variety of formats. The department is a member of the FDLP Content Partnerships Program and an Affiliated Archive of the National Archives.

Contact Us

What

Descriptive information to help identify this report. Follow the links below to find similar items on the Digital Library.

Description

A letter report issued by the General Accounting Office with an abstract that begins "Prescription drug diversion is the channeling of pharmaceuticals for illegal purposes or abuse. According to the Drug Enforcement Administration (DEA), increased prescription drug abuse and emergency room admissions, as well as the theft and illegal resale of prescription drugs, indicate that drug diversion is a growing problem associated with addiction, overdose, and death. All 15 state prescription drug monitoring programs (PDMP) collect information about the prescribing, dispensing, and use of prescription drugs and distribute it to medical practitioners, pharmacies, and state law enforcement and regulatory agencies. However, the programs differ in terms of objectives, design, and operations. In addition to helping law enforcement identify and prevent prescription drug diversion, program objectives also include education of the public, physicians, and pharmacists about the nature and extent of the problem, and medical treatment options for abusers of diverted drugs. The programs' designs vary by specific drugs covered and by the type of state agency in which they are housed. Some programs use the prescription data proactively to identify trends or patterns of use and to respond to law enforcement requests. Others use it only to respond to requests. States with PDMPs improve the timeliness of law enforcement and regulatory investigations. States considering establishing a PDMP, or expanding an existing one, face several challenges. These include educating the public and policymakers about prescription drug diversion and abuse and the benefits of a PDMP, responding to the concerns of physicians, patients, and pharmacists regarding the confidentiality of prescription information, and funding for program development and operations. National efforts to assist states in addressing illegal diversion have focused on providing guidance and technical assistance."

Subjects

Language

Item Type

Identifier

Unique identifying numbers for this report in the Digital Library or other systems.

Collections

This report is part of the following collection of related materials.

Government Accountability Office Reports

The U.S. Government Accountability Office (GAO) is an independent, nonpartisan agency that works for the U.S. Congress investigating how the federal government spends taxpayers' money. Its goal is to increase accountability and improve the performance of the federal government. The Government Accountability Office Reports Collection consists of over 13,000 documents on a variety of topics ranging from fiscal issues to international affairs.

What responsibilities do I have when using this report?

When

Dates and time periods associated with this report.

Creation Date

  • May 17, 2002

Added to The UNT Digital Library

  • June 11, 2014, 5:03 a.m.

Usage Statistics

When was this report last used?

Yesterday: 0
Past 30 days: 1
Total Uses: 14

Where

Geographical information about where this report originated or about its content.

Place Name

Publication Place

Map Information

  • map marker Automatically generated Place Name coordinates.
  • map marker Automatically generated Publication Place coordinates.
  • Repositioning map may be required for optimal printing.

Mapped Locations

Interact With This Report

Here are some suggestions for what to do next.

Start Reading

PDF Version Also Available for Download.

Citations, Rights, Re-Use

United States. General Accounting Office. Prescription Drugs: State Monitoring Programs Provide Useful Tool to Reduce Diversion, report, May 17, 2002; Washington D.C.. (digital.library.unt.edu/ark:/67531/metadc294949/: accessed October 23, 2017), University of North Texas Libraries, Digital Library, digital.library.unt.edu; crediting UNT Libraries Government Documents Department.